🔗 Visit the ClinicalTrials.gov page for NCT00361309
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. | J Clin Oncol | 2009 | 4.54 |
| 2 | Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer. | World J Gastroenterol | 2008 | 1.31 |
| 3 | Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy. | J Hematol Oncol | 2013 | 0.97 |
| 4 | Exploiting novel molecular targets in gastrointestinal cancers. | World J Gastroenterol | 2007 | 0.88 |
| 5 | Targeting the tumor stroma in hepatocellular carcinoma. | World J Hepatol | 2015 | 0.86 |
| 6 | Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives. | World J Gastroenterol | 2008 | 0.85 |